- Home
- TRNS vs AVBP Comparison
TRNS vs AVBP Comparison
Compare TRNS & AVBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRNS
- AVBP
- Stock Information
- Founded
- TRNS 1964
- AVBP 2021
- Country
- TRNS United States
- AVBP United States
- Employees
- TRNS N/A
- AVBP N/A
- Industry
- TRNS Electrical Products
- AVBP
- Sector
- TRNS Industrials
- AVBP
- Exchange
- TRNS Nasdaq
- AVBP NYSE
- Market Cap
- TRNS 1.1B
- AVBP 948.5M
- IPO Year
- TRNS N/A
- AVBP 2024
- Fundamental
- Price
- TRNS $103.99
- AVBP $26.01
- Analyst Decision
- TRNS Strong Buy
- AVBP Strong Buy
- Analyst Count
- TRNS 4
- AVBP 5
- Target Price
- TRNS $122.75
- AVBP $36.80
- AVG Volume (30 Days)
- TRNS 53.2K
- AVBP 144.5K
- Earning Date
- TRNS 01-27-2025
- AVBP 02-02-2025
- Dividend Yield
- TRNS N/A
- AVBP N/A
- EPS Growth
- TRNS 77.19
- AVBP N/A
- EPS
- TRNS 1.98
- AVBP N/A
- Revenue
- TRNS $270,612,000.00
- AVBP N/A
- Revenue This Year
- TRNS $10.53
- AVBP N/A
- Revenue Next Year
- TRNS $7.78
- AVBP N/A
- P/E Ratio
- TRNS $55.33
- AVBP N/A
- Revenue Growth
- TRNS 11.42
- AVBP N/A
- 52 Week Low
- TRNS $94.29
- AVBP $14.35
- 52 Week High
- TRNS $147.12
- AVBP $36.37
- Technical
- Relative Strength Index (RSI)
- TRNS 43.76
- AVBP 44.58
- Support Level
- TRNS $107.66
- AVBP $25.36
- Resistance Level
- TRNS $111.45
- AVBP $27.66
- Average True Range (ATR)
- TRNS 3.58
- AVBP 1.23
- MACD
- TRNS 0.54
- AVBP -0.16
- Stochastic Oscillator
- TRNS 26.79
- AVBP 37.56
About TRNS Transcat Inc.
Transcat Inc is involved in providing calibration and laboratory instrument services and distribution of test, measurement, and control instrumentation. Its product and services portfolio consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, etc. The firm has Service and Distribution operating segments. It derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Estech, FLIR, Fluke, Keysight, and Megger among others. It serves to pharmaceutical, industrial manufacturing, energy, and chemical process industries.
About AVBP ARRIVENT BIOPHARMA INC
ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize team's deep drug development experience to maximize the potential of lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.